Aaron Kucinski, Ph.D.
Affiliations: | 2012 | Anatomical Sciences | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Neuroscience BiologyGoogle:
"Aaron Kucinski"Mean distance: 35622
Parents
Sign in to add mentor| Michal Stachowiak | grad student | 2012 | SUNY Buffalo | |
| (Modeling of dopamine-dependent disorders in a transgenic mouse and therapeutic targeting of dopamine circuits through nicotinic acetylcholine receptors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kucinski A, Sarter M. (2021) Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071. Psychopharmacology |
| Sarter M, Avila C, Kucinski A, et al. (2021) Make a Left Turn: Cortico-Striatal Circuitry Mediating the Attentional Control of Complex Movements. Movement Disorders : Official Journal of the Movement Disorder Society |
| Kucinski A, Wersinger S, Stachowiak EK, et al. (2015) The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists. Behavioural Pharmacology. 26: 217-26 |
| Sarter M, Albin RL, Kucinski A, et al. (2014) Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Experimental Neurology. 257: 120-9 |
| Kucinski A, Curl R, Miletich RS, et al. (2014) The role of fibroblast growth factor (FGF) signaling on dopaminergic function in Parkinson's disease The Central Catecholaminergic System: Anatomy, Functions and Disorders. 143-156 |
| Miletich RS, Kucinski A, Narla S, et al. (2014) Schizophrenia and the dopaminergic system The Central Catecholaminergic System: Anatomy, Functions and Disorders. 157-177 |
| Kucinski A, Wersinger S, Stachowiak EK, et al. (2013) Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease. Pharmacology, Biochemistry, and Behavior. 111: 1-10 |
| Stachowiak MK, Kucinski A, Curl R, et al. (2013) Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophrenia Research. 143: 367-76 |
| Bencherif M, Stachowiak MK, Kucinski AJ, et al. (2012) Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia. Medical Hypotheses. 78: 594-600 |
| Kucinski A, Syposs C, Wersinger S, et al. (2012) α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia. Schizophrenia Research. 136: 82-7 |